Phosphoric Acid — predicted protein targets

Known targets — ChEMBL curated mechanism

ADRA1A ADRA1B ADRA1D ADRB1 ADRB2 ADRB3 CYP11B1 DPP4 FGFR1 FGFR2 FGFR3 FGFR4 HRH1 JAK1 JAK2 JAK3 KCNA1 KCNA10 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 KCNB1 KCNB2 KCNC1 KCNC2 KCNC3 KCNC4 KCND1 KCND2 KCND3 KCNF1 KCNG1 KCNG2 KCNG3 KCNG4 KCNH1 KCNH2 KCNH3 KCNH4 KCNH5 KCNH6 KCNH7 KCNH8 KCNQ1 KCNQ2 KCNQ3 KCNQ4 KCNQ5 KCNS1 KCNS2 KCNS3 KCNV1 KCNV2 KDR KIT NA OPRD1 OPRK1 OPRM1 P PDGFRB PIK3CD SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SMO TYK2 pol rplA rplB rplC rplD rplE rplF rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmC rpmD rpmE rpmF rpmG rpmH rpmI rpmJ rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsS rpsT rpsU ykgM ykgO

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	KDR known ✓	P35968	2/20	0.93

▸	TGFBR1	P36897	17/20	0.93

▸	MAPK14	Q16539	7/20	0.93

▸	PDGFRA	P16234	1/20	0.93

▸	FLT1	P17948	1/20	0.93

▸	FLT4	P35916	1/20	0.93

▸	PRKD1	Q15139	1/20	0.93

▸	RIPK2	O43353	1/20	0.79

▸	ACVR1B	P36896	1/20	0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL4875304	0.97	TGFBR1 (1.00)	TGFBR1MAPK14KDRPDGFRAFLT1
SCHEMBL30373643	0.97	TGFBR1 (1.00)	TGFBR1MAPK14KDRPDGFRAFLT1
Sulfuric Acid SCHEMBL4876156	0.93	TGFBR1 (0.93)	TGFBR1MAPK14KDRPDGFRAFLT1
SCHEMBL4872543	0.90	TGFBR1 (0.87)	TGFBR1MAPK14KDRPDGFRAFLT1
SCHEMBL4872463	0.89	TGFBR1 (0.85)	TGFBR1MAPK14KDRPDGFRAFLT1
SCHEMBL4875054	0.89	TGFBR1 (0.85)	TGFBR1MAPK14KDRPDGFRAFLT1
SCHEMBL4874162	0.89	TGFBR1 (0.85)	TGFBR1MAPK14KDRPDGFRAFLT1
SCHEMBL4877281	0.88	TGFBR1 (0.81)	TGFBR1MAPK14KDRPDGFRAFLT1
SCHEMBL4874930	0.88	TGFBR1 (0.84)	TGFBR1MAPK14KDRPDGFRAFLT1
SCHEMBL29504112	0.88	TGFBR1 (1.00)	TGFBR1MAPK14KDRPDGFRAFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20130245066-A1	2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors	IN2GEN CO., LTD. (KR)	2013-09-19	—	—	US	disclosed
US-20080319012-A1	2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors	IN2GEN CO., LTD. (KR)	2008-12-25	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20130245066-A1	2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors	ALK, ERBB4, ACVR1	KDR 9/4885TGFBR1 93/4885MAPK14 478/4885
US-20080319012-A1	2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors	ALK, ERBB4, ACVR1	KDR 9/4885TGFBR1 93/4885MAPK14 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.